Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy B Davis

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|January 8, 2021
Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case ReportsMatthew D Tucker, Kathryn E Beckermann, Jennifer B Gordetsky, et al.
International Journal of Molecular Sciences|November 25, 2023
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab VedotinCatherine C Fahey, Caroline A Nebhan, Sally York, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium studyNancy B Davis, David A Taber, Rafat H Ansari, et al.
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society GuidelineLarissa Nekhlyudov, Christina Lacchetti, Nancy B Davis, et al.
Cancer|June 23, 2021
Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort studyKyle A Dymanus, Mohit Butaney, Diana E Magee, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2024
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3Petros Grivas, Damien Pouessel, Chandler H Park, et al.
Biomarker Research|November 4, 2021
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinomaMatthew D Tucker, Landon C Brown, Yu-Wei Chen, et al.
JCI Insight|November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinomaChristopher G Wood, James E Ferguson, Joel S Parker, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|January 8, 2021
Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case ReportsMatthew D Tucker, Kathryn E Beckermann, Jennifer B Gordetsky, et al.
International Journal of Molecular Sciences|November 25, 2023
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab VedotinCatherine C Fahey, Caroline A Nebhan, Sally York, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium studyNancy B Davis, David A Taber, Rafat H Ansari, et al.
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society GuidelineLarissa Nekhlyudov, Christina Lacchetti, Nancy B Davis, et al.
Cancer|June 23, 2021
Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort studyKyle A Dymanus, Mohit Butaney, Diana E Magee, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2024
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3Petros Grivas, Damien Pouessel, Chandler H Park, et al.
Biomarker Research|November 4, 2021
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinomaMatthew D Tucker, Landon C Brown, Yu-Wei Chen, et al.
JCI Insight|November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinomaChristopher G Wood, James E Ferguson, Joel S Parker, et al.
Pageof 3